Soothe

Uses and Indications

This drug is indicated for external use only. There are no teratogenic effects associated with its use, and no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, the product should not be used without consulting a healthcare professional. It is essential to seek medical advice before administering this treatment to this age group.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no identified risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

Contact with the eyes should be strictly avoided to prevent irritation or injury.

In the event that conditions worsen, or if symptoms persist for more than 7 days, it is imperative to discontinue use of this product. Should symptoms resolve and then reoccur within a few days, the patient must refrain from using any other hydrocortisone product without prior consultation with a healthcare professional. This precaution is essential to ensure appropriate management and to avoid potential complications.

Side Effects

Patients should be advised to avoid contact with the eyes while using this product. In clinical practice, if conditions worsen or if symptoms persist for more than 7 days, it is recommended that patients discontinue use of the product. Furthermore, if symptoms clear up and then recur within a few days, patients should refrain from using any other hydrocortisone product without first consulting a healthcare professional. These precautions are essential to ensure patient safety and to prevent potential complications associated with prolonged use or inappropriate application of hydrocortisone products.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Soothe (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, the use of this medication is not recommended; consultation with a healthcare professional is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that there are no specific safety concerns or dosage modifications related to the use of this medication during pregnancy as detailed in the prescribing information. Additionally, no special precautions regarding the use of this medication in pregnant individuals have been provided. Healthcare professionals should consider the absence of explicit pregnancy-related data when advising women of childbearing potential and weigh the benefits against any potential risks when prescribing this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of seeking immediate medical assistance or contacting a poison control center if the medication is swallowed. This information is vital for ensuring patient safety and preventing potential adverse effects associated with accidental ingestion.

Storage and Handling

The product is supplied in a configuration that ensures safety and efficacy. It is essential to keep the product out of reach of children to prevent accidental ingestion or misuse. This product is intended for external use only, and appropriate precautions should be taken to avoid contact with eyes and mucous membranes.

Storage conditions should be carefully observed to maintain product integrity. It is recommended to store the product in a cool, dry place, away from direct sunlight and heat sources. Special handling requirements include ensuring that the container is tightly closed when not in use to prevent contamination and degradation of the product.

Additional Clinical Information

No further data are available.